Nomura analyst Jialin Zhang maintained a Hold rating on MicroPort Scientific (MCRPF – Research Report) today and set a price target of HK$7.19. The company’s shares closed last Friday at $0.97.
According to TipRanks, Zhang is an analyst with an average return of -17.3% and a 18.75% success rate. Zhang covers the Healthcare sector, focusing on stocks such as Innovent Biologics, MicroPort Scientific, and Wuxi Biologics (Cayman).
The word on The Street in general, suggests a Hold analyst consensus rating for MicroPort Scientific with a $0.92 average price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $2.78 and a one-year low of $0.73. Currently, MicroPort Scientific has an average volume of 14.07K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MicroPort Scientific (MCRPF) Company Description:
MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture and distribution of medical devices. It operates through the following segments: Orthopedics Devices Business; Cardiovascular Devices Business; Endovascular Devices Business; Electrophysiology Devices Business; Neurovascular Devices Business; Surgical Management Business; and Diabetes Care and Endocrinal Business. The company was founded by Zhaohua Chang in 1998 and is headquartered in Shanghai, China.
